Navigation Links
Vet-Stem and Central Veterinary Research Labs of Dubai Sign Exclusive License
Date:9/13/2007

SAN DIEGO, Sept. 13 /PRNewswire/ -- Vet-Stem, Inc., the global leader in regenerative veterinary medicine, has licensed their proprietary stem cell technology to the Central Veterinary Research Laboratory (CVRL) of Dubai in the United Arab Emirates. The license allows the laboratory to offer adipose- derived stem cell services to animal owners throughout the Middle East region. The ruler of Dubai and Prime Minister of the United Arab Emirates, Sheik Mohammed bin Rashid al-Maktoum, is one of the world's largest thoroughbred owners and sponsors the richest horse racing day, the Dubai World Cup. "The Central Veterinary Research Laboratory will be an excellent partner in bringing this technology from the US to the Middle East as they are already the most respected reference lab in the region," says Dr. Bob Harman, CEO of Vet-Stem. The CVRL intends to provide stem cell services for treatment of injuries in thoroughbred race horses, Arabian endurance horses, racing camels, and many other species. Vet-Stem's clients in the United States have already treated over 2500 horses and over 100 dogs with arthritis, tendon, and ligament injuries with a success rate of over 70% return to normal performance.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060425/VETSTEMLOGO)

Vet-Stem delivers stem and other regenerative cells from a small fat sample for use in treating an animal's own injuries. This clearly avoids the controversy of using stem cells taken from embryos. This technology provides the opportunity for regeneration and healing of tendon and ligament injuries instead of the normal scarring process which reduces performance and may increase chances of re-injury. Stem cells are delivered to the veterinarian only 48 hours after a small fat sample is collected from the injured animal. Priority overnight shipment has allowed Vet-Stem to develop veterinary clients in all parts of the country and has eliminated regional issues typically associated with service expansion. "Our success in animals is directly translatable to humans, said Robert J. Harman, DVM, MPVM CEO Vet-Stem, Inc., "and we wish to share our evidence that stem cells are safe and effective".

About Vet-Stem, Inc.

Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. This privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals.

In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. Since that time there has been rapid adoption of this technology for treatment of tendon, ligament, and joint injuries by the veterinary community. Studies have shown that mesenchymal stem cells can dramatically improve the healing of injuries and diseases that have had very few treatment options in the past.

For additional information, contact:

Vet-Stem, Inc.

Dr. Julie Ryan Johnson

12860 Danielson Court, Suite BPoway, CA 92064

858-748-2004

info@vet-stem.com


'/>"/>
SOURCE Vet-Stem, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Madison start-up Central Signal gets $350K grant
2. Will wireless Internet bypass the central city?
3. Norlight to expand fiber network into central Illinois
4. Centralization mania takes over
5. Meterologix Media Division acquired by Madison-based Weather Central
6. Weather Central launches second satellite
7. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
8. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
9. Control Your siRNA Research
10. Getting Started with MicroRNA Research
11. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 18, 2017 , ... LabRoots , the leading ... the world, was today awarded the "Best Science & Technology Social Networking Service ... and decided upon by a dedicated team of researchers and analysts. , The ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita ... full spectrum of drug and device development, and Prism Clinical Research , ... clinicians, today announced Verified Clinical Trials (VCT) has been selected by ...
(Date:1/19/2017)... Md. , Jan. 18, 2017  Northwest Biotherapeutics, ... developing DCVax® personalized immune therapies for operable and inoperable ... Bosch , Chief Technical Officer of NW Bio, will ... January 19, 2017, at the Hyatt Regency Hotel in ... Bosch will chair the session entitled "New Therapeutic Approaches ...
(Date:1/19/2017)... 18, 2017 BD (Becton, Dickinson and Company) (NYSE: ... it will host a live webcast of its Annual Meeting of ... The webcast can be accessed from the BD corporate ... Tuesday, January 31, 2017. ... About BD BD is a global medical technology ...
Breaking Biology Technology:
(Date:1/12/2017)... , Jan. 12, 2017  New research undertaken by ... office of the future.  1,000 participants were simply asked which ... months which we may consider standard issue.  Insights on what ... 2017 were also gathered from futurists and industry leaders including ... James Canton .  Some of ...
(Date:1/6/2017)... BOULDER, Colo. , Jan. 5, 2017 /PRNewswire/ ... join the "Digital Life Alliance" established by iCarbonX, ... in 2015 to build a "Global Digital Health ... based on a combination of individual,s biological, behavioral ... Under the agreement between the companies, SomaLogic will ...
(Date:12/22/2016)... , Dec. 20, 2016  As part of its longstanding ... leading personal genetics company, recently released its latest children,s book, ... The book focuses on the topics of inheritance and variation ... Standards (NGSS) taught in elementary school classrooms in the US. ... series by illustrator Ariana Killoran , whose previous book ...
Breaking Biology News(10 mins):